ProCE Banner Activity

Shifting Paradigms: Treating HER2-Positive or Microsatellite Unstable mCRC

Clinical Thought

Released: June 05, 2023

Share

Faculty

Robert Lentz

Robert Lentz, MD

Assistant Professor of Medicine
Department of Medicine
Division of Medical Oncology
University of Colorado School of Medicine and Cancer Center
Aurora, Colorado

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner

Supporters

This activity is supported by educational grants from Merck Sharp & Dohme, LLC and Seagen.

Merck Sharp & Dohme, LLC

Seagen

Disclosure

Primary Author

Robert Lentz, MD

Assistant Professor of Medicine
Department of Medicine
Division of Medical Oncology
University of Colorado School of Medicine and Cancer Center
Aurora, Colorado

Robert Lentz, MD: researcher: ALX Oncology, Lilly, Merck.